Rodney Alexander Rosalia

The Histone Methyltransferase Ezh2 Controls Mechanisms of Adaptive Resistance to Tumor Immunotherapy

Daniel Zingg, Natalia Arenas-Ramirez, Dilara Şahin et al. · Cell Reports · 2017 · 321 citations · Full text

CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses

Rodney Alexander Rosalia, Luis J. Cruz, Suzanne van Duikeren et al. · Biomaterials · 2014 · 265 citations

Vaccination, Nanomedicine, Cross-protection +10

Targeting nanoparticles to CD40, DEC-205 or CD11c molecules on dendritic cells for efficient CD8+ T cell response: A comparative study

Luis J. Cruz, Rodney Alexander Rosalia, Jan Willem Kleinovink et al. · Journal of Controlled Release · 2014 · 223 citations

Nanomedicine, Immunology, Therapeutic Vaccine +11

Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T‐cell activation

Rodney Alexander Rosalia, Esther D. Quakkelaar, Anke Redeker et al. · European Journal of Immunology · 2013 · 204 citations · Full text

Poly-(lactic-co-glycolic-acid)-based particulate vaccines: Particle uptake by dendritic cells is a key parameter for immune activation

Ana L Silva, Rodney Alexander Rosalia, Eleni Maria Varypataki et al. · Vaccine · 2015 · 120 citations

Vaccination, Inflammation, Mucosal Vaccination +13